MIRCERA GETS POSITIVE OPINION IN EUROPE FOR ANAEMIA

摘要

Roche,Basel,Switzerland,has received a positive opinion from the European Committee for Medicinal Products for Human Use(CHMP)recommending a marketing authorization be granted for MIRCERA for the treatment of anaemia associated with chronic kidney disease.MIRCERA is a new long-acting chemically synthesized erythropoiesis-stimulating agent(ESA).